Yu. A. Stepanova

Medical Technologies (Czechia)

Papers

1

Total Citations

1

H-Index

1

About

Yu. A. Stepanova is a leading surgical oncologist whose work focuses on the management of advanced renal cell carcinoma (RCC), particularly the rare and life-threatening complication of inferior vena cava (IVC) tumor thrombus. Her most cited paper, "Surgical treatment of inferior vena cava tumor thrombus" (2022), systematically reviews the prognostic significance of venous invasion and metastatic spread in RCC, synthesizing existing knowledge to guide clinical decision-making. This work has garnered 1 citation, reflecting its targeted relevance to specialists in urologic oncology and complex hepatobiliary surgery. Dr. Stepanova’s contributions are pivotal in refining surgical strategies for high-risk patients, emphasizing the importance of aggressive thrombectomy in improving survival outcomes. Her research bridges the gap between surgical technique and oncologic prognosis, offering a framework for managing one of the most challenging presentations of kidney cancer. As a clinician-researcher, she continues to advance the field by integrating evidence-based approaches into the operative management of IVC tumor thrombi, making her a key voice in the evolving landscape of RCC treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Surgical treatment of inferior vena cava tumor thrombus.
1 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Medical Technologies (Czechia)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago